Trimeris trimeris.com


Public lists: Pharma Startups (4743)

Trimeris is a development stage, biopharmaceutical company engaged in the discovery and development of novel therapeutic agents that block viral infection by inhibiting viral fusion with host cells. Trimeris' lead product candidate, T-20, is now entering Phase III clinical trials. Trimeris' second fusion inhibitor product candidate, T-1249, which also inhibits HIV fusion, has received fast-track designation from the FDA and is undergoing Phase I/II clinical testing.

Trimeris is a development stage, biopharmaceutical company engaged in the discovery and development of novel therapeutic agents that block viral infection by inhibiting viral fusion with host cells. Trimeris' lead product candidate, T-20, is now ente...Show all

Company (Acquired)

Phone: 919-806-4682

Fax:

2530 Meridian Parkway
2nd Floor
Durham, 27713
North Carolina, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Trimeris $30.4M Jun 23, 2011
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Trimeris Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 32 investors

Board Members

Competitors

Company Status Description Investors
See all 15 competitors